gBRCA1/2 mutations increase the incidence of breast cancer (BC) by interrupting the homologous recombination repair (HRR) pathway. Although gBRCA1 and gBRCA2 BC have similar clinical profiles, differe
Cancer is a genetic disease caused by an accumulation of mutations, however many of these mutations have been identified in pathologically normal tissue. We aim to use laser-capture microscopy (LCM) t
PURPOSE: Cancer of unknown primary (CUP) is a group of metastatic tumors in which the standard diagnostic work-up fails to identify the site of origin of the tumor. The potential impact of precision o
The data and code used in the manuscript entitled "Identification and Validation of a Gene-based Signature Reveals SLC25A10 as a Novel Prognostic Indicator for Patients with Ovarian Cancer".
Genome resequencing of B. subtilis mutant strain resulting from random recombinations between strains NCIB 3610 and RO-NN-1. Strain is mostly RO-NN-1 (~80%) but the rest includes randomly swapped snip
